PATENT CLAIM ANALYSIS

Application Number: 16138286
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "654000"]

Abstract:
The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical solution is kept under anaerobic conditions from its formulation to its administration.

Claim (Index 4):
The pharmaceutical composition for use according to  claim 1 , wherein said solution is adapted to be administered into brain ventricle, preferably into right lateral ventricle, preferably close to the interventricular foramen.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 97.0
- Lexical Diversity: 1.16129
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15310364', '12384935', '11102521', '13647155', '09887854']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.762406249952998
- 35 USC 102 Novelty (BERT): 0.6170495027488333
- Combined Prediction Score: 0.7478705752325815
- Mean Citation Score: 364.717536
- Max Citation Score: 577.16754
- Similarity Product: 477.58913657165056

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test